JP2009509928A5 - - Google Patents

Download PDF

Info

Publication number
JP2009509928A5
JP2009509928A5 JP2008529292A JP2008529292A JP2009509928A5 JP 2009509928 A5 JP2009509928 A5 JP 2009509928A5 JP 2008529292 A JP2008529292 A JP 2008529292A JP 2008529292 A JP2008529292 A JP 2008529292A JP 2009509928 A5 JP2009509928 A5 JP 2009509928A5
Authority
JP
Japan
Prior art keywords
alkyl
group
phenyl
halogen
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008529292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009509928A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/034128 external-priority patent/WO2007027959A1/en
Publication of JP2009509928A publication Critical patent/JP2009509928A/ja
Publication of JP2009509928A5 publication Critical patent/JP2009509928A5/ja
Pending legal-status Critical Current

Links

JP2008529292A 2005-09-01 2006-08-30 カリウムチャンネル開口剤としての新規ベンゾピラン誘導体 Pending JP2009509928A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71332305P 2005-09-01 2005-09-01
PCT/US2006/034128 WO2007027959A1 (en) 2005-09-01 2006-08-30 Novel benzopyran derivatives as potassium channel openers

Publications (2)

Publication Number Publication Date
JP2009509928A JP2009509928A (ja) 2009-03-12
JP2009509928A5 true JP2009509928A5 (enExample) 2009-10-01

Family

ID=37401455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008529292A Pending JP2009509928A (ja) 2005-09-01 2006-08-30 カリウムチャンネル開口剤としての新規ベンゾピラン誘導体

Country Status (13)

Country Link
US (1) US7838553B2 (enExample)
EP (1) EP1937669B9 (enExample)
JP (1) JP2009509928A (enExample)
CN (1) CN101296925A (enExample)
AT (1) ATE543813T1 (enExample)
AU (1) AU2006284675A1 (enExample)
CA (1) CA2620894A1 (enExample)
DK (1) DK1937669T3 (enExample)
ES (1) ES2379098T3 (enExample)
PL (1) PL1937669T3 (enExample)
PT (1) PT1937669E (enExample)
SI (1) SI1937669T1 (enExample)
WO (1) WO2007027959A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009509927A (ja) * 2005-09-01 2009-03-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カリウムチャンネル開口剤としての新規ベンゾピラン誘導体
JP6063870B2 (ja) 2010-11-08 2017-01-18 ライセラ・コーポレイション RORγ活性の阻害用のN−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
RU2014149136A (ru) 2012-05-08 2016-07-10 Мерк Шарп И Доум Корп. ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ
CA2871504C (en) * 2012-05-08 2020-07-21 Merck Sharp & Dohme Corp. Bicyclic sulfone compounds for inhibition of rorgamma activity and the treatment of disease
EP2847198B1 (en) 2012-05-08 2016-12-14 Lycera Corporation Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror-gamma and the treatment of disease
WO2015095795A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE, AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
WO2015095788A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. 2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
WO2015095792A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Carbamate benzoxaxine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
AU2015222917A1 (en) 2014-02-27 2016-09-15 Lycera Corporation Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
WO2015171558A2 (en) 2014-05-05 2015-11-12 Lycera Corporation BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
EP3140291A4 (en) 2014-05-05 2018-01-10 Lycera Corporation Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
CA2975997A1 (en) 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
WO2016179343A1 (en) 2015-05-05 2016-11-10 Lycera Corporation DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
CN107980042B (zh) 2015-06-11 2021-10-08 莱斯拉公司 用作RORγ激动剂和用于治疗疾病的芳基二氢-2H-苯并[b][1,4]噁嗪磺酰胺和相关化合物
EP3368516B1 (en) 2015-10-27 2020-07-15 Merck Sharp & Dohme Corp. SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
US10287272B2 (en) 2015-10-27 2019-05-14 Merck Sharp & Dohme Corp. Substituted indazole compounds as RORgammaT inhibitors and uses thereof
JP2018531958A (ja) 2015-10-27 2018-11-01 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. RORγT阻害薬としてのヘテロアリール置換安息香酸及びその使用
CN116535379B (zh) * 2023-06-29 2023-09-19 希格生科(深圳)有限公司 化合物及其医药用途

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH594675A5 (enExample) * 1976-01-30 1978-01-13 Ciba Geigy Ag
ATE56007T1 (de) 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
EP0205292B1 (en) 1985-06-08 1991-11-06 Beecham Group Plc Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
DE3669317D1 (de) * 1985-09-11 1990-04-12 Beecham Group Plc Chromanderivate und aehnliche verbindungen mit blutdrucksenkender wirkung.
DE3726261A1 (de) 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
US4971982A (en) 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
DE3732146A1 (de) 1987-09-24 1989-04-06 Merck Patent Gmbh Azachromanderivate
US5254557A (en) * 1988-05-09 1993-10-19 Beecham Group P.L.C. Compound and treatment
DE3823533A1 (de) * 1988-07-12 1990-02-08 Beiersdorf Ag Substituierte 4-heterocyclyl-2h-benzo(b)pyrane, verfahren und 4-hydroxy-3-brom-, 3,4-oxiranyl-3,4-dehydro-2h-benzo(b)pyrane als zwischenprodukte zu ihrer herstellung, sowie sie enthaltende pharmazeutsche praeparate
ES2071668T3 (es) * 1988-12-13 1995-07-01 Beecham Group Plc Benzopirano y compuestos relacionados.
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
GB8916683D0 (en) 1989-07-21 1989-09-06 Beecham Group Plc Novel compounds
US4983612A (en) * 1989-10-05 1991-01-08 American Home Products Corporation Antihypertensive benzopyran derivatives
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US5171857A (en) * 1990-03-29 1992-12-15 American Home Products Corporation Antihypertensive benzopyran derivatives
GB2242628A (en) 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
US5254578A (en) * 1990-10-24 1993-10-19 Sankyo Company, Limited Benzopyran derivatives having anti-hypertensive and vasodilatory activity and their therapeutic use
US5310932A (en) * 1991-04-15 1994-05-10 E. R. Squibb & Sons, Inc. Chromanyl substituted indole potassium channel openers
US5206252A (en) * 1992-05-08 1993-04-27 American Home Products Corporation Thiadiazolyl-amino derivatives of benzopyrans and indanes
US5225566A (en) 1992-05-08 1993-07-06 American Home Products Corporation Indazolanonyl derivative of benzopyran
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
US6253627B1 (en) * 2000-06-12 2001-07-03 The United States Of America As Represented By The Secretary Of The Navy Thin-line towed-array force measurement apparatus and method
KR20140015122A (ko) 2003-10-01 2014-02-06 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
JP2009509927A (ja) * 2005-09-01 2009-03-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カリウムチャンネル開口剤としての新規ベンゾピラン誘導体

Similar Documents

Publication Publication Date Title
WO2004074270A3 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
JP2016506960A5 (enExample)
JP2009538897A5 (enExample)
RU2007119562A (ru) Тетрациклические производные индолов в качестве противовирусных агентов
RU2011116227A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
JP2018533611A5 (enExample)
JP2008526999A5 (enExample)
RU2012110246A (ru) Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
JP2014037426A5 (enExample)
CA2492723A1 (en) Novel 2,5-disubstituted pyrimidine derivatives
JP2011509309A5 (enExample)
CA2628131A1 (en) Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
ES2437346T3 (es) Procedimiento para la producción de derivado de diamina
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
CA2564629A1 (en) Substituted phenylaminopyrimidines
JP2015535834A5 (enExample)
JP2006502119A5 (enExample)
JP2013508382A5 (enExample)
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
CA2728098A1 (en) Pyrazole-containing tricyclic compounds as_antagonits of an ep1 receptor
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2006511446A5 (enExample)
JP2005538111A5 (enExample)
RU2009103300A (ru) Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии
RU2435760C2 (ru) 1н-хиназолин-2,4-дионы